Solara Active Pharma Sciences Limited
SOLARA
Rank in Stocks
#13964
Solara Active Pharma Sciences Limited is an Indian-based pharmaceutical company... Solara Active Pharma Sciences Limited is an Indian-based pharmaceutical company primarily involved in the comprehensive development, production, and global trade of active pharmaceutical ingredients (APIs). Their activities span the manufacturing, processing, sale, import, and export of these essential drug components. The company's extensive product range includes APIs designed for a wide spectrum of therapeutic applications, such as anesthetics, antibiotics, antivirals, cardiovascular agents, central nervous system treatments, anti-inflammatory drugs, and treatments for metabolic disorders like type-II diabetes, among numerous other specialized categories. Beyond its core product offerings, Solara also delivers specialized contract research and manufacturing services (CRAMS) for APIs. These services encompass custom development and manufacturing, analytical support, impurity synthesis, and comprehensive regulatory assistance. The company maintains a significant international presence, exporting its products and conducting operations across diverse global regions, including the Asia Pacific, Europe, North America, and South America. Headquartered in Chennai, India, Solara Active Pharma Sciences Limited was established in 2017. Initially known as SSL Pharma Sciences Limited, the company adopted its current name in March of the same year.
Share Price
$7.33
Last synced: 2026-11-13
Market Cap
$352.54M
Change (1 day)
1.60%
Change (1 year)
13.51%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Solara Active Pharma Sciences Limited (SOLARA)
Category
Healthcare
EPS for Solara Active Pharma Sciences Limited (SOLARA)
EPS as of September 2026 TTM: $0.08
According to Solara Active Pharma Sciences Limited's latest financial reports, its current EPS (TTM) is $0.08. At the end of 2025 the company had an EPS of 0.00, an increase over its 2024 EPS of $-1.74.
EPS history for Solara Active Pharma Sciences Limited from 2017 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.08 | -100.09% |
| 2025 | 0.00 | -100.09% |
| 2024 | $-1.74 | 2,222.93% |
| 2023 | $-0.08 | -64.81% |
| 2022 | $-0.21 | -124.53% |
| 2021 | $0.87 | 47.76% |
| 2020 | $0.59 | 69.33% |
| 2019 | $0.35 | 14,995.65% |
| 2018 | 0.00 | -99.45% |
| 2017 | $0.42 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | 7,916.52% |
DE
|
|
| $6.08 | 7,393.96% |
DE
|
|
| $1.55 | 1,811.96% |
JP
|
|
| $3.66 | 4,412.95% |
CH
|
|
| $0.45 | 454.87% |
IL
|
Questions about Solara Active Pharma Sciences Limited's earnings per share (EPS)
What is Solara Active Pharma Sciences Limited's earnings per share (EPS)?
Solara Active Pharma Sciences Limited's earnings per share (EPS) over the last twelve months is $0.08, as of Sep 2026.
What was Solara Active Pharma Sciences Limited's earnings per share (EPS) in 2025?
In 2025, Solara Active Pharma Sciences Limited's earnings per share (EPS) was 0.00, compared with $-1.74 in 2024.
How has Solara Active Pharma Sciences Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Solara Active Pharma Sciences Limited's earnings per share (EPS) was highest in 2021 ($0.87) and lowest in 2024 ($-1.74).
How does Solara Active Pharma Sciences Limited's earnings per share (EPS) compare with similar companies?
Solara Active Pharma Sciences Limited's earnings per share (EPS) ($0.08) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.